Three thematic areas have been developed as priorities for investment. Each of these thematic areas is core for the success of the partnership:
Brain Therapies
Driving breakthroughs in Brain Science and Mental Health.
Brain therapies refer to a spectrum of advanced medical and neurotechnological interventions aimed at treating neurological and neurodegenerative conditions. Bringing together expertise in genomics, neuroscience, psychiatry, and data science to tackle some of society’s most urgent challenges, such as dementia, schizophrenia, movement disorders, bipolar disorder, neuroinflammatory disease and neurodevelopmental disorders. Our work focuses on translating genetic discoveries into real-world personalised and advanced therapies.
Cardiff is emerging as a global centre for first-in-human intracranial advanced therapies, where treatments are delivered directly to the brain. This is supported by CUBRIC and the Medicines Discovery Institute, offering world-class imaging, genomics, and surgical expertise.
Next generation cancer care
Researching and delivering the next generation of treatments for complex cancer.
Cardiff is home to leading clinical and academic cancer research expertise, both in laboratory science and clinical trials. Cardiff Health Partners leverages these strengths, combining them with capabilities in genomics, diagnostics, data science and NHS cancer services to take cancer treatment to the next level.
A new specialist Velindre Cancer Centre, a short walk from Cardiff Edge, hardwires collaboration across discovery, development, and delivery. The nearby University Hospital of Wales provides national expertise, within walking distance to key discovery and translational research institutes, including the Cardiff Experimental Cancer Medicines Centre Wales Cancer Research Centre), Wales Cancer Bank, and Medicines Discovery Institute. Together, these form the Cardiff Cancer Innovation District (CCID). With cancer rates above the UK average, Cardiff is a real world testbed to trial and scale new ways of preventing, diagnosing, and treating cancer.
The Cardiff Cancer Research Partnership
The Cardiff Cancer Research Partnership (CCRP) is designed to improve outcomes, deliver world-class research, enable advanced therapies, and create a structured pipeline from discovery to clinical application. The Partnership has a vibrant and sustainable pipeline of trial activity. Progress to date has been strong but expansion is limited by current space and workforce capacity.
Precision Medicine
Tailoring prevention and treatment strategy for our population’s health.
Precision medicine uses genetic testing, data analytics, and biomarkers to understand how different people respond to disease and therapy, improving outcomes and efficiency. Precision medicine relies heavily on the ability to collect, integrate, and analyse large-scale genomic, imaging, clinical, and biobank data.
Our priority is to build a federated data, imaging, and biobank capability that enables secure, interoperable access across institutions, bridging discovery science to clinical application at pace.
Cardiff Edge is the leading dedicated life science and tech campus in Cardiff and South-East Wales region. With 320,000 square foot of expansion space, it offers a unique opportunity to create an exemplar life sciences ecosystem connecting business, academia and NHS laboratory facilities at a single location. The first lab-enabled facility is planned to be developed imminently.Cardiff is emerging as a global centre for first-in-human intracranial advanced therapies, where treatments are delivered directly to the brain. This is supported by CUBRIC and the Medicines Discovery Institute, offering world-class imaging, genomics, and surgical expertise.
